Pasar al contenido principal

Investigación y educación

Enviado por remote_content el

Diaz A. Quantitative sensory testing: a good tool to identify subclinical neuropathy in ATTRV30M amyloidosis patients? Amyloid.

Investigación y Educación

"Background Quantitative sensory testing (QST) has been one of the neurophysiological tools used for follow-up and disease progression assessment in ATTRv amyloidosis. We aimed to detect the utility of QST in identifying subclinical neuropathic involvement in ATTRV30M amyloidosis carriers.

Conclusions QST, in particular CDT, HP 5 and HP 0.5 modalities, seems a good tool to identify subclinical neuropathy in ATTRv amyloidosis carriers, with CDT showing a higher sensitivity to detect and early neuropathic involvement."

Read full article

Artículos que te pueden interesar

Neurología

"Radiofrequency Treatment of Iliac and Paravertebral Cluneal Nerves for Low Back Pain. Pain Physician."

Octubre 25, 2022

Leer más

Neurología

"Multiple sclerosis care units in Latin America: Consensus recommendations about its objectives and functioning implementation. J Neurol Sci."

Octubre 15, 2021

Leer más

Neurología

Clinical, pathological and genetic characteristics of Perry disease-new cases and literature review. Eur J Neurol.

Agosto 26, 2021

Leer más